Princess Margaret Cancer Centre, Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
Princess Margaret Cancer Centre, Department of Biostatistics, University of Toronto, Toronto, Ontario, Canada.
JAMA Otolaryngol Head Neck Surg. 2017 Apr 1;143(4):368-375. doi: 10.1001/jamaoto.2016.3668.
Advances in surgical techniques, the advent of intensity-modulated radiotherapy (IMRT), and the use of concurrent chemotherapy in oral squamous cell carcinoma (OSCC) have led to improvement of locoregional control (LRC), but not distant control (DC). Moreover, the development of distant metastases (DM) in OSCC has a dismal prognosis.
To determine the characteristics and risk factors of DM following postoperative IMRT in OSCC, and to identify the clinicopathological features that could be associated with distant-only failure (DOF).
DESIGN, SETTING, AND PARTICIPANTS: Retrospective study of 300 OSCC patients (192 [64%] men and 108 [36%] women) treated with surgery and postoperative IMRT between 2005-2012 in a tertiary cancer center.
All patients underwent initial primary curative-intent resection with postoperative IMRT with or without concurrent chemotherapy based on predefined risk features.
Locoregional control, DC, overall survival (OS), and Radiation Therapy Oncology Group grade of 3 or higher late toxic effects. Multivariable analysis identified predictors for DM.
Overall 300 patients were identified (histological grade 2-3 [G2-3], 285 [95%]; pT3-4, 121 [41%]; pN2-3, 141 [47%]). Positive resection margin was present in 64 of 300 (21%) patients and extracapsular extension in 89 of 281 (32%) neck dissections. Median IMRT dose was 66 Gy and concurrent chemotherapy was used in 73 patients (24%). Median follow-up was 41 months. The 5-year local, regional, and distant control and OS were 85%, 82%, 86%, and 69%, respectively. On multivariable analysis, pN2-3 (hazards ratio, 5.7; 95% CI, 2.2-14.7) and G2-3 (HR, 4.9; 95% CI, 2.8-8.9) were predictive of DM. Thirty-nine patients developed DM, of which 20 (51%) were DOF and 12 (31%) were oligometastatic (≤5 lesions). The clinicopathological characteristics in DOF were similar to patients with DM subsequent to locoregional failure. In patients with G2-3, pN2-3, and extracapsullar extension (all together), the 5-year cumulative incidence of DOF was 22%.
Surgery and postoperative IMRT with or without concurrent chemotherapy achieved encouraging outcomes. The clinicopathological characteristics of DOF and DM with locoregional failure were similar. Patients with G2-3, pN2-3, and extracapsullar extension (all together) have higher risk of DOF. Both pN2-3 and G2-3 were independent predictors of DM. Patients with these risk factors may be candidates for prospective clinical trials of intensified therapy or surveillance strategies.
重要性:手术技术的进步、调强放疗(IMRT)的出现以及在口腔鳞状细胞癌(OSCC)中同步化疗的应用,导致局部区域控制(LRC)得到改善,但远处控制(DC)没有改善。此外,OSCC 远处转移(DM)的发展预后不良。
目的:确定接受术后 IMRT 的 OSCC 患者发生 DM 的特征和危险因素,并确定与远处失败(DOF)相关的临床病理特征。
设计、设置和参与者:对 2005 年至 2012 年期间在一家三级癌症中心接受手术和术后 IMRT 治疗的 300 例 OSCC 患者(192 例[64%]男性和 108 例[36%]女性)进行回顾性研究。
干预措施:所有患者均接受初始原发性根治性切除术,并根据预设的风险特征进行术后 IMRT 治疗,同时或不进行同步化疗。
主要结局和测量:局部区域控制、DC、总生存率(OS)和放射治疗肿瘤学组 3 级或更高的晚期毒性作用。多变量分析确定了 DM 的预测因素。
结果:共确定了 300 例患者(组织学分级 2-3[G2-3],285 例[95%];pT3-4,121 例[41%];pN2-3,141 例[47%])。300 例患者中,64 例(21%)存在阳性切缘,281 例颈清扫术中有 89 例(32%)存在包膜外扩展。中位 IMRT 剂量为 66Gy,73 例(24%)患者接受同步化疗。中位随访时间为 41 个月。5 年局部、区域和远处控制率和 OS 率分别为 85%、82%、86%和 69%。多变量分析显示,pN2-3(风险比,5.7;95%CI,2.2-14.7)和 G2-3(HR,4.9;95%CI,2.8-8.9)是 DM 的预测因素。39 例患者发生 DM,其中 20 例(51%)为 DOF,12 例(31%)为寡转移(≤5 个病灶)。在 DOF 患者中,G2-3、pN2-3 和包膜外扩展(全部)的 5 年累积 DOF 发生率为 22%。
结论和相关性:手术和术后 IMRT 联合或不联合同步化疗取得了令人鼓舞的结果。DOF 和 DM 与局部区域失败的临床病理特征相似。G2-3、pN2-3 和包膜外扩展(全部)的患者 DOF 风险较高。pN2-3 和 G2-3 均为 DM 的独立预测因素。具有这些危险因素的患者可能是强化治疗或监测策略前瞻性临床试验的候选者。